References
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the predictions of cardiovascular disease in women. N Engl J Med 2000; 342:836-843.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and risks of cardiovascular events in apparently healthy men. N Engl J Med 1997;336:973-979.
Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. For the Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999;100:230-235.
National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-1445.
Kothe H, Dalhoff K, Rupp J, et al. Hydroxymethylglutarylcoenzmye a reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation 2000 101:1760-1763
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dzien, A., Dzien-Bischinger, C., Hoppichler, F. et al. Statin Therapy and Plasma C-Reactive Protein Levels in Primary Prevention. Cardiovasc Drugs Ther 14, 699–700 (2000). https://doi.org/10.1023/A:1007887503287
Issue Date:
DOI: https://doi.org/10.1023/A:1007887503287